Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/04/2013 | US20130084298 Novel anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof |
04/04/2013 | US20130084297 Anti-ErbB3 Antibodies and Uses Thereof |
04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
04/04/2013 | US20130084293 Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammation |
04/04/2013 | US20130084291 Compositions and methods for increasing serum half-life |
04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
04/04/2013 | US20130084289 Treatment of multiple sclerosis |
04/04/2013 | US20130084288 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
04/04/2013 | US20130084285 Treatment with anti-alpha2 integrin antibodies |
04/04/2013 | US20130084284 Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof |
04/04/2013 | US20130084283 Oligomer-specific amyloid beta epitope and antibodies |
04/04/2013 | US20130084282 Compositions and methods for targeting type 1 interferon producing cells |
04/04/2013 | US20130084243 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
04/04/2013 | CA2850720A1 Binding molecule having influenza a virus-neutralizing activity produced from human b cell |
04/04/2013 | CA2850567A1 Identification of antigen-specific adaptive immune responses using arm-pcr and high-throughput sequencing |
04/04/2013 | CA2850549A1 Antibodies against tl1a and uses thereof |
04/04/2013 | CA2850542A1 Therapeutic peptides |
04/04/2013 | CA2850407A1 Increasing virus-like particle yield in plants |
04/04/2013 | CA2850322A1 Antigen-binding molecule inducing immune response to target antigen |
04/04/2013 | CA2850291A1 Multi-specific binding molecules targeting aberrant cells |
04/04/2013 | CA2850261A1 Biological materials related to c-met |
04/04/2013 | CA2850054A1 Igy composition for use in celiac disease |
04/04/2013 | CA2850041A1 Ion concentration-dependent binding molecule library |
04/04/2013 | CA2850035A1 Therapeutic antigen-binding molecule with a fcrn-binding domain that promotes antigen clearance |
04/04/2013 | CA2849765A1 Hybrid constant regions |
04/04/2013 | CA2849746A1 Anti-icam-1 antibodies to treat multiple-myeloma related disorders |
04/04/2013 | CA2849508A1 Anti-erbb3 antibodies and uses thereof |
04/04/2013 | CA2849466A1 Use of il-1.beta. binding antibodies |
04/04/2013 | CA2849033A1 Immunocytokine combination therapy |
04/04/2013 | CA2847826A1 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
04/03/2013 | EP2574666A1 Method for producing antigen-specific antibodies via in vitro immunisation |
04/03/2013 | EP2574630A1 Antibodies that bind il-4 and/or il-13 and their uses |
04/03/2013 | EP2574629A1 Antibodies that bind il-4 and/or il-13 and their uses |
04/03/2013 | EP2574628A1 Ferroportin antibodies and methods of use |
04/03/2013 | EP2574627A1 Particular uses of CD24 inhibitors |
04/03/2013 | EP2574626A1 Antibodies that bind IL-4 and/or IL-13 and their uses |
04/03/2013 | EP2574625A1 Remedy for renal disease |
04/03/2013 | EP2574346A1 Cytokine-expressing cellular vaccine combinations |
04/03/2013 | EP2574345A1 Humanized antibodies to amyloid beta |
04/03/2013 | CN1622958B Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
04/03/2013 | CN103026231A Reagent and reagent kit for measurement of FDP, and measurement method |
04/03/2013 | CN103025871A Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method |
04/03/2013 | CN103025761A Humanized anti-interleukin 3 receptor alpha chain antibodies |
04/03/2013 | CN103025760A Humanized EGFR antibodies |
04/03/2013 | CN103025759A Cross-species-specific psmaxcd3 bispecific single chain antibody |
04/03/2013 | CN103025758A IL-1 binding proteins |
04/03/2013 | CN103025358A Factor viia complex using an immunoglobulin fragment |
04/03/2013 | CN103025354A Treatment drug for autoimmune diseases and allergic diseases |
04/03/2013 | CN103025353A Treatment methods |
04/03/2013 | CN103014155A New markers for cancers |
04/03/2013 | CN103014047A Recombined human cystatin-C protein with natural activity and preparation method thereof |
04/03/2013 | CN103014034A Method for preparing creatinekinase isoenzyme and application |
04/03/2013 | CN103014033A Method for preparing alanine aminotransferase and application |
04/03/2013 | CN103014028A Method for preparing lactate dehydrogenase and application |
04/03/2013 | CN103014014A Preparation method and application of brain natriuretic peptide |
04/03/2013 | CN103014012A Fusarium specific single-chain antibody and preparation method and application thereof |
04/03/2013 | CN103013929A Avian influenza virus, and detection kit and vaccine thereof |
04/03/2013 | CN103013928A H9N2 avian influenza virus and application thereof |
04/03/2013 | CN103013927A Application of anti-cellular-prion-protein monoclonal antibody in preparing antitumor drugs |
04/03/2013 | CN103013926A Anti-cellular-prion-protein monoclonal antibody and application of in diagnostic test kit |
04/03/2013 | CN103013925A Bispecific monoclonal antibody, preparation method and uses thereof |
04/03/2013 | CN103012593A Preparation and applications of clenbuterol monoclonal antibody |
04/03/2013 | CN103012592A Preparation and applications of ractopamine monoclonal antibody |
04/03/2013 | CN103012591A Monoclonal antibody for resisting Benzonase, and preparation method and application thereof |
04/03/2013 | CN103012590A Anti-CD20 monoclonal antibody, preparation method and application thereof |
04/03/2013 | CN103012589A Human anti-vascular endothelial cell growth factor antibody and application thereof |
04/03/2013 | CN103012588A Targeted therapy of tumors by using McAb capable of neutralizing VEGFA biological activity |
04/03/2013 | CN103012587A Preparation, identification and application of monoclonal antibody of specific human lung resisting specific X protein |
04/03/2013 | CN103012586A Recombinant antibodies and fragments recognising ganglioside N-glycolyl-GM3 and use thereof in the diagnosis and treatment of tumours |
04/03/2013 | CN103012585A Polyclonal antibody of integral membrane protein and preparation method thereof |
04/03/2013 | CN103012583A Connection method of paralytic shellfish poison and carrier protein |
04/03/2013 | CN103007280A Piglet colibacillosis lyophilized serum immunoglobulin preparation and preparation process thereof |
04/03/2013 | CN103007279A Human anti-epidermal growth factor receptor antibody |
04/03/2013 | CN103007278A Anti-porphyromonas gingivalis and fusobacterium nucleatum compound specific IgY antibody, preparation method and toothpaste thereof |
04/03/2013 | CN102321173B Humanized macrophage inhibitory factor 1 monoclonal antibody and application thereof |
04/03/2013 | CN102296050B Anti-human IL-1alpha monoclonal antibody and application thereof |
04/03/2013 | CN102199575B Corn chlorotic mottle virus monoclonal antibody and application thereof |
04/03/2013 | CN102127148B Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
04/03/2013 | CN101899100B Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof |
04/03/2013 | CN101815726B Monoclonal antibodies against glypican-3 |
04/03/2013 | CN101759781B Protein adhered to surface layers of bacteria and application thereof |
04/03/2013 | CN101426814B Compositions and methods for humanization and optimization of n-glycans in plants |
04/03/2013 | CN101356195B Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 |
04/03/2013 | CN101351476B Antibodies with glycosylated in the variable region |
04/03/2013 | CN101313063B Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen |
04/03/2013 | CN101046478B Method for detecting n-terminal pre-BNP |
04/02/2013 | US8412461 Systems and methods for antibody engineering |
04/02/2013 | US8410333 Humanized immunoglobulin loci |
04/02/2013 | US8410253 Scavenger receptor |
04/02/2013 | US8410252 ULBP2 polypeptides |
04/02/2013 | US8410251 Antibody against calcified globule and use of the same |
04/02/2013 | US8410250 Anti-FGFR3 antibodies and methods using same |
04/02/2013 | US8410249 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
04/02/2013 | US8410058 Methods of using insulin-like growth factor antibodies to treat tumors |
04/02/2013 | US8409821 Detection of hypertension using glucuronidated metabolic products |
04/02/2013 | US8409817 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
04/02/2013 | US8409814 Sensor proteins and assay methods |
04/02/2013 | US8409810 Platelet aggregation assays using a CD40L-binding agent |
04/02/2013 | US8409579 Humanized anti-FGF19 antagonists and methods using same |